Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia by van Wijk, Diederik F., MD, Sjouke, Barbara, MD, Figueroa, Amparo, MD, Emami, Hamed, MD, van der Valk, Fleur M., MD, MacNabb, Megan H., BA, Hemphill, Linda C., MD, Schulte, Dominik M., MD, PhD, Koopman, Marion G., MD, PhD, Lobatto, Mark E., MD, Verberne, Hein J., MD, PhD, Fayad, Zahi A., MD, PhD, Kastelein, John J.P., MD, PhD, Mulder, Willem J.M., PhD, Hovingh, G. Kees, MD, PhD, Tawakol, Ahmed, MD, Stroes, Erik S.G., MD, PhD

Get full text

Next-generation sequencing to confirm clinical familial hypercholesterolemia by Reeskamp, Laurens F, Tromp, Tycho R, Defesche, Joep C, Grefhorst, Aldo, Stroes, Erik Sg, Hovingh, G Kees, Zuurbier, Linda

Get full text

Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study by Stoekenbroek, Robert M, Boekholdt, S Matthijs, Luben, Robert, Hovingh, G Kees, Zwinderman, Aeilko H, Wareham, Nicholas J, Khaw, Kay-Tee, Peters, Ron J G

Get full text

The potential of glucagon-like peptide-1 receptor agonists in heart failure by Kreiner, Frederik Flindt, Hovingh, G. Kees Kornelis, von Scholten, Bernt Johan

Get full text

Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms by Verbeek, Rutger, MD, Sandhu, Manjinder S., PhD, Hovingh, G. Kees, MD, PhD, Sjouke, Barbara, MD, Wareham, Nicholas J., MBBS, PhD, Zwinderman, Aeilko H., PhD, Kastelein, John J.P., MD, PhD, Khaw, Kay-Tee, MBBChir, Tsimikas, Sotirios, MD, Boekholdt, S. Matthijs, MD, PhD

Get full text

Very low LDL-cholesterol concentrations achieved: which target is next? by Hovingh, G Kees, Boekholdt, S Matthijs, Stroes, Erik S

Get full text

Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials by Bays, Harold E., Rosenson, Robert S., Baccara-Dinet, Marie T., Louie, Michael J., Thompson, Desmond, Hovingh, G. Kees

Get full text

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis by de Groot, Eric, Hovingh, G Kees, Wiegman, Albert, Duriez, Patrick, Smit, Andries J, Fruchart, Jean-Charles, Kastelein, John J P

Get full text

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI by Vallejo-Vaz, Antonio J., Bray, Sarah, Villa, Guillermo, Brandts, Julia, Kiru, Gaia, Murphy, Jennifer, Banach, Maciej, De Servi, Stefano, Gaita, Dan, Gouni-Berthold, Ioanna, Kees Hovingh, G., Jozwiak, Jacek J., Jukema, J. Wouter, Gabor Kiss, Robert, Kownator, Serge, Iversen, Helle K., Maher, Vincent, Masana, Luis, Parkhomenko, Alexander, Peeters, André, Clifford, Piers, Raslova, Katarina, Siostrzonek, Peter, Romeo, Stefano, Tousoulis, Dimitrios, Vlachopoulos, Charalambos, Vrablik, Michal, Catapano, Alberico L., Poulter, Neil R., Ray, Kausik K.

Get full text

Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort by Thompson, John F, Hyde, Craig L, Wood, Linda S, Paciga, Sara A, Hinds, David A, Cox, David R, Hovingh, G. Kees, Kastelein, John J.P

Get full text

eNOS activation by HDL is impaired in genetic CETP deficiency by Gomaraschi, Monica, Ossoli, Alice, Pozzi, Silvia, Nilsson, Peter, Cefalù, Angelo B, Averna, Maurizio, Kuivenhoven, Jan Albert, Hovingh, G Kees, Veglia, Fabrizio, Franceschini, Guido, Calabresi, Laura

Get full text

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition by Kraaijenhof, Jordan M, Cronjé, Héléne T, Hovingh, G Kees, Nurmohamed, Nick S, Gill, Dipender, Zagkos, Loukas

Get full text

Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia by Gaudet, Daniel, Ruzza, Andrea, Bridges, Ian, Maruff, Paul, Schembri, Adrian, Hamer, Andrew, Mach, François, Bergeron, Jean, Gaudet, Isabelle, Pierre, Julie St, Kastelein, John J.P., Hovingh, G. Kees, Wiegman, Albert, Raal, Frederick J., Santos, Raul D.

Get full text

Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study by Oostveen, Reindert F, Kaiser, Yannick, Hartgers, Merel L, Meessen, Emma C E, Grefhorst, Aldo, Hovingh, G Kees, Kuipers, Folkert, Stroes, Erik S G, Groen, Albert K, Reeskamp, Laurens F

Get full text

High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity by Chantepie, Sandrine, Bochem, Andrea E, Chapman, M John, Hovingh, G Kees, Kontush, Anatol

Get full text

Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar by Preiss, David, Tobert, Jonathan A, Hovingh, G Kees, Reith, Christina

Get full text

Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study by Verbeek, Rutger, Boekholdt, S Matthijs, Stoekenbroek, Robert M, Hovingh, G Kees, Witztum, Joseph L, Wareham, Nicholas J, Sandhu, Manjinder S, Khaw, Kay-Tee, Tsimikas, Sotirios

Get full text

Familial hypercholesterolemia treatments: Guidelines and new therapies by Raal, Frederick J., Hovingh, G. Kees, Catapano, Alberico L.

Get full text

Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials by Bangalore, Sripal, MD, MHA, Fayyad, Rana, PhD, Hovingh, G. Kees, MD, Laskey, Rachel, PhD, Vogt, Liffert, MD, DeMicco, David A., PharmD, Waters, David D., MD

Get full text

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe by Harada-Shiba, Mariko, Kastelein, John J.P., Hovingh, G. Kees, Ray, Kausik K., Ohtake, Akira, Arisaka, Osamu, Ohta, Takao, Okada, Tomoo, Suganami, Hideki, Wiegman, Albert

Get full text